Fundraising Fox
BroadOak Capital Partners
Venture capitalBethesda · 8 people tracked
Also known as Broad · BROADOAK ASSET MANAGEMENT, LLC
Find your way into BroadOak Capital Partners
Sign up to see every warm intro you have to BroadOak Capital Partners
- Paths you didn't know you had: your email and LinkedIn already hold routes to the BroadOak Capital Partners team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Fund manager profile
BroadOak Capital Partners is a venture fund manager based in Bethesda. SEC filings show 1 venture fund on record, most recently BROADOAK CAPITAL 2018B, LLC ($11.2M offering) filed September 2021.
Source: SEC EDGAR Form D filings. Firm website data not yet available.
Team · 8 people
from public directories
What they invest in
from 11 of 12 portfolio companiesBiotech ×9Deep Tech ×5Medical Devices ×4Advanced Manufacturing ×2Enterprise Software ×2Hardware ×2Healthtech ×2AI & Machine Learning ×1
HQs:United States×12
Investments · 12 tracked
founders shown can be your intro pathBy year:2026 · 22024 · 22022 · 12021 · 12018 · 17 dated
PAK BioSolutions builds automated systems and single-use flow kits for end-to-end continuous purification of biopharmaceuticals, running four continuous purification stages simultaneously for a stated 4X productivity gain over batch methods.
Advanced ManufacturingBiotechHardwareBurke, US
Pezzini Joanna(President)inKevin Hill-Byrne(Co-Founder & CTO)in
Co-investorsArboretum Ventures
Indee Labs develops Hydropore™, a non-viral microfluidic technology for delivering molecules, nucleic acids, proteins, and gene-editing complexes into immune cells for engineered cell therapy research and manufacturing.
BiotechDeep TechHealthtechMedical DevicesSan Francisco, US
Ryan Pawell(CEO)inAdrian Lievano(Bioengineer)Amy Twite,Eva Welles(HR Consultant)
Co-investorsJude GomilaPioneerY CombinatorFounders FundMain Sequence VenturesSOSV
Kromatid provides single-cell structural genomic analysis tools for cell and gene therapy companies, enabling assessment of genomic integrity and identification of complex structural rearrangements during therapy development.
AI & Machine LearningBiotechDeep TechMedical DevicesLongmont, US
Andrew Jost(Executive Officer)James Chomas(Executive Officer, Director)Christopher Tompkins(Executive Officer, Director)Susan Bailey(Executive Officer)Joel Bedford(Director)
BoardTerry Opgenorth(Director)
PBS Biotech develops Vertical-Wheel bioreactors and related accessories for scalable manufacturing of cell therapies, including allogeneic therapies derived from induced pluripotent stem cells, mesenchymal stem cells, and CAR-T or NK cells.
BiotechHardwareMedical DevicesCamarillo, US
Brian Lee(Executive Officer, Director)inMatt Croughan(Executive Officer)Nelson Bermudez(Executive Officer)inTerrell Mathews(Executive Officer)inBryan Poltilove(Director)Jung Lim(Director)
Co-investorsAvego BioScience Capital
Pluristyx develops induced pluripotent stem cell (iPSC) technologies, including non-modified and genetically engineered cell lines, proprietary gene edits, and reprogramming platforms, along with related services.
BiotechDeep TechMedical DevicesSeattle, US
Benjamin Fryer(Executive Officer, Director, Promoter)inJason Carstens(Executive Officer, Director)Trent Carrier(Director)
Quartzy provides a platform for lab management and research resource optimization, serving life scientists, lab managers, and academic institutions.
BiotechDeep TechE-commerceEnterprise SoftwareHealthtechSaaSSan Francisco, US
Jayant Kulkarni(CEO)inAdam Regelmann(CPO)inAjoy Sojan(CTO)sylvie.dao@quartzy.comTristan Pemble(Director of Engineering)Courtney Bogaard(Director of HR)
Co-investorsA.Capital VenturesBling CapitalLerer HippeauMultiplier CapitalSilicon BadiaTeamworthy Ventures+10 more
S2.dev builds infrastructure services and tools for developers.
Cloud ComputingData & InfrastructureDeveloper ToolsEnterprise SoftwareSan Francisco, US
Shikhar Bhushan(CEO)inStephen Balogh(CTO)inDwarak Govind Parthiban(Founder)inMehul ArorainCristian Caciucin
Co-investorsGrayscale VenturesMaterialized View CapitalOrange CollectivePioneerTranspose Platform ManagementUncorrelated Ventures+11 more
seqWell develops reagents and technologies for next-generation sequencing library preparation, serving academic and institutional research clients.
BiotechDeep TechBeverly, US
Thomas Grant(Executive Officer)inDaniel Calvo(Executive Officer, Director)JoeJackJoseph Mellor(Executive Officer, Director)Joseph Mellor, Ph.D.(Executive Officer, Director)
Co-investorsResearch Corporation Technologies
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Portfolio news
latest coverage across their companies
s2.dev · economictimes.indiatimes.com · Aug 8, 2026
Quartzy · finsmes.com · Apr 16, 2026
Frequently asked questions
- How many investments has BroadOak Capital Partners made?
- BroadOak Capital Partners has 12 tracked investments, including 2 dated in the last 24 months.
- Where is BroadOak Capital Partners located?
- BroadOak Capital Partners is headquartered in Bethesda, US.